Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban and PCC: Prothrombin Complex Concentrate in patients with bleeding complications related to Rivaroxaban
2013-004484-31Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Nov 2013
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of balfaxar in anticoagulant-associated bleeding and coagulation defects, sponsored by Medical University of Innsbruck. Started Nov 2013; status: completed.
02
Drugs
balfaxar
03
Conditions
anticoagulant-associated bleedingcoagulation defects
Beyond the preview
Go deeper on 2013-004484-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004484-31.